o2h ventures has so far invested in 25 promising early stage biotech companies in the UK from the Human Health EIS fund as well as angel investments.
our full portfolio
Order
Default
A-Z
Z-A
Default
Status
All
Active
Exited
All
Therapeutics Area
All
All
Investment Type
All
Fund Investment
Pre-Fund Investment
All
Sorry, no results found with this search